Stay updated on Cabozantinib for Young Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib for Young Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0, while the page remains a 403 Forbidden error screen.
    Difference
    0.2%
    Check dated 2026-10-31T22:06:14.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page.
    Difference
    1%
    Check dated 2026-10-24T22:26:23.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The error page footer now displays site revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-17T22:28:43.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer's revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:20:10.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now shows a 403 error, replacing the study details with an access-denied message.
    Difference
    20%
    Check dated 2026-09-19T22:01:04.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6, indicating a deployment of a newer version. This is an internal maintenance update reflected on the page rather than a modification to the study information.
    Difference
    0.0%
    Check dated 2026-08-29T18:27:58.000Z thumbnail image

Stay in the know with updates to Cabozantinib for Young Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Young Solid Tumors Clinical Trial page.